Business
Traffic is back: Road use quickly rebounded

Traffic is back: Road use quickly rebounded

The one thing that did bounce back quickly? Traffic.

Traffic is back

The sharp rebound in traffic — even in dense cities like New York — is particularly interesting. Data from the MTA reveals that Subway usage in the Big Apple is hovering around 70% of what it used to be pre-pandemic — a figure that, like office occupancy, hasn't budged much this year. However, usage of the cities bridges and tunnels has been back to normal pretty much since late 2021, recovering quickly from the traffic-free days of the pandemic.

Mining from home

Obviously, remote working isn't suitable for every profession. Data from the American Community Survey confirms what you might expect; writers and authors, economists and market researchers, software developers, management analysts and mathematical scientists are the occupations with the highest share of remote workers (all north of 60%). On the flip side, butchers, metal and plastic workers, mining machine operators and highway maintenance workers are all overwhelmingly working as normal, with just 2-3% of people in those occupations working remotely.

More Business

See all Business
business

Monster surges on energy drink buzz, while Celsius sinks on distribution concerns

Shares of Monster Beverage climbed 5% after the bell on Thursday, and held most of those gains into early trading on Friday, following strong Q3 results.

The energy drink giant topped market expectations, with quarterly sales up 17% year-over-year to $2.2 billion and adjusted net profits growing 41% to $524.5 million — 11% ahead of Wall Street’s estimates. In the report, Monster highlighted its zero-sugar line and new product launches, with a stack of novel flavors already released this year, as bright spots.

During a call with analysts, Chief Executive Hilton Schlosberg said that the global energy drink category “remains healthy with robust growth,” the WSJ reported, adding that demand for more affordable caffeinated drinks is rising as coffee has become “really expensive.”

Meanwhile, rival beverage business Celsius saw shares fall as much as 23% on its Q3 results yesterday — despite beating expectations, with revenue jumping 173% — largely due to concerns about a change in the company’s distribution channel, as its newly acquired Alani Nu brand joins the PepsiCo distribution network.

President Trump Announces Negotiated Lower Prices For GLP-1 Weight Loss Drugs

White House unveils deal with Novo, Lilly on weight-loss drugs

The latest deal the administration has reached with Big Pharma is perhaps the one that would impact the highest number of Americans.

Mounjaro injections

Blockbuster drug sales power Big Pharma’s Q3 earnings as tariff fears fade

Meanwhile, Novo Nordisk and Pfizer are in an escalating bid-off for obesity biotech Metsera.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.